Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neuroblastoma × Vorinostat × Clear all

Phase

Status

Completed 5 Unknown 2 Recruiting 1 Not yet recruiting 1 No longer available 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 1 Primary Malignant Peripheral Nerve Sheath Tumors 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroblastoma 1 Leukemia, Myeloid, Acute 1

Interventions

Temozolomide 13 Irinotecan 10 Cyclophosphamide 8 naxitamab 7 dinutuximab 6 sargramostim 5 Vincristine 5 Granulocyte-Macrophage Colony-Stimulating Factor 5 Melphalan 4 Eflornithine 4 Carboplatin 4 fludarabine 3 Zoledronic Acid 3 Etoposide 3 Doxorubicin 3 saponin QA-21V1 2 lutetium Lu 177 dotatate 2 etoposide phosphate 2 aldesleukin 2 Topotecan 2 Thiotepa 2 Specimen Handling 2 Interleukin-2 2 Granulocyte Colony-Stimulating Factor 2 Colony-Stimulating Factors 2 Cisplatin 2 Busulfan 2 3-fluorobenzylguanidine 2 3-Iodobenzylguanidine 2 tipifarnib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02559778 2026-02-20

PEDS-PLAN

Milton S. Hershey Medical Center

Phase 2 Recruiting

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡